Endotracheal Tube Market - By Product Type, By Material, By Route of Intubation, By Application, By End Use - Global Forecast, 2025 - 2034

Endotracheal Tube Market Size

The global endotracheal tube market was valued at USD 2.2 billion in 2024. The market is expected to reach from USD 2.3 billion in 2025 to USD 4.2 billion in 2034, growing at a CAGR of 6.8% during the forecast period. The high market growth can be attributed to the growing number of surgeries requiring intubation, rise in ICU admissions and critical care patients, expansion of healthcare infrastructure in emerging markets, and rising incidence of chronic respiratory diseases, among other contributing factors.
 

The global prevalence of chronic obstructive pulmonary disease (COPD) and asthma is rising worldwide, especially in older populations. For instance, according to the WHO, COPD is the most prevalent respiratory disorder with 392 million cases, followed by asthma with 339 million cases in 2023. Similarly, the CDC also reported in 2022 that COPD was the 6th leading cause of death worldwide in 2020 with 3.23 million deaths. These disorders require endotracheal tubes for airway management during acute episodes, raising their demand. In 2023, the American Lung Association reported that environmental pollution is responsible for around 137,000 premature deaths every year in the U.S., further supporting the expansion of this market.
 

In addition, manufacturers also include new subglottic suction, antimicrobial covering, and new cuff designs to reduce complications like ventilator associated pneumonia (VAP). These improvements not only impact the patient positively but also accelerate the adoption of healthcare in the best centers, thereby expanding the market.
 

An endotracheal (ET) tube is a flexible medical device employed to access the trachea through the mouth or nose to sustain air passage and ensure ventilation during surgeries, anesthesia, or critical care. ETTs facilitate mechanical ventilation and safeguard the airway from contamination. ETTs are indispensable in surgical, critical care, and emergency settings.
 

Endotracheal Tube Market Trends

The market is witnessing significant growth driven by rising prevalence of respiratory diseases, shift toward disposable and single-use tubes, rising adoption of video laryngoscopy for intubation, growing use in out-of-hospital and emergency settings, and surging need for integrated antimicrobial and drug-eluting coatings, among other factors are boosting the industry growth.
 

• Emergency medical services (EMS) and military healthcare professionals are implementing technologically sophisticated endotracheal tubes which streamline sequential airway control. The National Emergency Medical Services Information System (NEMSIS) reported that the EMS activations in the U.S. climbed from 32.8 million in 2021 to 35.6 million in 2023.
   
• The U.S. Department of Defense (DoD) increased spending on emergency medical equipment by 12% between the years 2022 and 2024, illustrating the growing focus on portable healthcare solutions and emergency response capabilities.
   
• In addition, advanced market development has been triggered by public health programs intended to broaden the scope of respiratory healthcare access and early diagnosis. The Global Initiative for Chronic Obstructive Lung Disease (GOLD), WHO’s respiratory care plans, and national programs for the management of mechanically ventilated patients seek to improve the care of patients requiring mechanical ventilation. These programs also work to reduce the ventilator-dependent infections, mortality and length of stay in ICU, which drives the global demand for endotracheal tubes of higher quality in healthcare facilities.
   

Endotracheal tube Market Analysis

Based on product type, the market is classified into regular endotracheal tube, reinforced endotracheal tube, performed endotracheal tube, and double lumen endotracheal tube. The regular endotracheal tube generated the highest revenue of USD 1 billion in 2024.
 

• Regular endotracheal tubes are preferred for routine surgical and emergency procedures, especially in resource-poor regions as they are cheaper than specialized and advanced types. According to the World Health Organization (WHO) 2023 report, public hospitals in developing nations spent 40-60% less on basic medical supplies by opting for regular endotracheal tubes over specialized variants.
   
• The U.S. Centers for Medicare and Medicaid Services, standard endotracheal tubes resulted in a cost savings of USD 2,500-3,000 for healthcare facilities per 100 procedures in 2022. Moreover, an outpatient surgical center usage survey conducted in 2021 by the American Hospital Association found that 78% of these centers used regular endotracheal tubes due to cost control measures.
   
• Moreover, these tubes are easy to use and have a straightforward design which most anesthesiologists and emergency personnel have been trained to operate. Their uniformity aids instruction within clinical practice, which ensures expeditious implementation, and therefore, reinforces their consistent preference for routine and emergency intubations supporting segmental growth.
   

Based on material, the endotracheal tube market is classified into polyvinyl chloride (PVC), silicon, polyurethane and other materials. The polyvinyl chloride (PVC) segment accounted for USD 1.4 billion in market revenue in 2024 and is anticipated to grow at a CAGR of 6.7% between the 2025 to 2034 period.
 

• PVC is a polymer that is widely used and inexpensive, which makes it a good option for large scale production of endotracheal tubes. In lower- and middle-income countries, healthcare facilities can afford to purchase and stock large quantities without overwhelming budget constraints.
   
• Biocompatibility of medical-grade PVC, along with its long-standing non-reactive use in tissue engineering makes it a favorable option in airway devices. Biocompatible materials with non-reactive means PVC does not irritate body tissues ensuring a wide acceptability among patients, including those undergoing insignificant surgical interventions or those requiring temporary short-term mechanical ventilation.
   
• Additionally, due to the low costs associated with sterilization, PVC remains the top selection for single use and disposable tubes. As the world increasingly focuses on infection control and the use of disposable devices, the demand for these tubes continues to grow significantly.
   

Based on route of intubation, the endotracheal tube market is classified into orotracheal and nasotracheal. The orotracheal segment accounted for USD 1.7 billion in market revenue in 2024 and is anticipated to grow at a CAGR of 7% between the 2025 to 2034 period.
 

• Orotracheal intubation remains the most common method of airway management in emergencies because it is fast and easy to perform. During trauma or in cases of cardiac arrest and during critical care, two orotracheal tubes can be secured within two minutes, greatly expediting airway access for ventilatory support. This is why ambulance services, ERs, and ICUs across the world have such a strong preference for this method.
   
• Orotracheal intubation does not result in complications such as nasal bleeding and sinus infections which occur more often with nasotracheal tubes. For many patients, the anatomical profile of orotracheal intubation is safer, which makes it more advantageous in comparison to nasotracheal intubation, especially in adult patients with no contraindications.
   
• Furthermore, orotracheal intubation is taught as a primary response to issues with airway obstruction in most medical schools and residents worldwide. The promotion and use of this method by many institutions reinforces its dominance in clinical practice and contributes to sustained demand in the market.
   

Based on application, the endotracheal tube market is classified into general surgery, emergency treatment, therapy, neonatal and pediatric care, and other applications. The general surgery segment dominated the market in 2024 with a market share of 38%
 

• The global number of both elective and non-elective surgeries including abdominal, orthopedic, and cardiovascular procedures persists to grow leading to increasing demand for endotracheal intubation. Global data shows that there were around 321 million surgical procedures conducted around the world in 2022, which is 12% growth as compared to 2021. Any general surgery will require controlled ventilation using general anesthesia, and endotracheal tubes.
   
• Furthermore, there is an increasing prevalence of chronic diseases requiring surgical intervention which supports market growth. Chronic disease surgeries alone saw a 15% increase from 2021 to 2023 (CDC). Developed countries, along with emerging economies, have improved their surgical capabilities which raised the need for dependable airway management systems. From 2022 to 2023, emerging economies witnessed an 18% increase in the development of surgical infrastructure (World Bank Healthcare Infrastructure Report).
   
• In the Asia-Pacific region, Latin America, and sections of Africa, both public and private investments in healthcare are resulting in the expansion of surgical centers and operating theaters. This infrastructure development includes the outfitting of facilities with standard airway and anesthetic equipment, for example, endotracheal tubes. As general surgery grows in accessibility, the number of procedures performed is rising, thus increasing the demand for both disposable and reusable endotracheal tubes.

Based on end use, the endotracheal tube market is segmented into hospitals, ambulatory surgical centres, and other end users. The hospitals segment dominated the market in 2024 and is anticipated to reach USD 2.8 billion by the end of the forecast period.
 

• The hospitals, especially the tertiary and multi-specialty centers, handle high number of surgical and ICU admissions where endotracheal intubation is done routinely. There is a market demand for endotracheal tubes due to general mechanical ventilation requirements during anesthesia or in cases of ventilatory failure. Their use in the management of complicated trauma, septic situations, and recovery from surgeries ensure constant use of the products in both emergency and elective surgical cases.
   
• In addition, with growing awareness of hospital-acquired infections (HAIs), hospitals are favoring single-use, disposable endotracheal tubes to reduce cross-contamination risks. Regulatory policies and hospital accreditation standards further reinforce this shift. As a result, there's a steady uptick in demand for sterile, disposable airway devices tailored for hospital environments.

The U.S. endotracheal tube market was valued at USD 678 million and USD 711.8 million in 2021 and 2022, respectively. The market size reached USD 785.5 million in 2024, growing from USD 747.6 million in 2023.
 

• The growing incidence of respiratory diseases like chronic obstructive pulmonary disease (COPD), and other conditions such as pneumonia and acute respiratory distress syndrome (ARDS), has greatly increased the need of endotracheal tubes (ETT) in the country. For example, the CDC reported that COPD was diagnosed in more than 16 million Americans in 2024, and pneumonia still remains one of the most common diseases for hospital admissions. Therefore, effective management of these chronic diseases is directly propelling the demand for enhanced airway management systems, thereby increasing the usage of endotracheal tubes in healthcare facilities.
   
• In addition, policies set by Medicare, Medicaid, and private insurers in the U.S. reimburse for both intubation and mechanical ventilation procedures. This form of financial backing encourages best practice adherence by hospitals and surgery centers, which in most cases requires endotracheal intubation during surgical or mechanical ventilation procedures. Hence, these policies support adoption without facing economic difficulties, thereby leading to market growth in the country.
   

Europe endotracheal tube market accounted for USD 636.1 million in 2024 and is anticipated to show lucrative growth over the forecast period.
 

• The European Union maintains absolute control over medical device safety and performance under the Medical Device Regulation (MDR) which supports the uptake of high-quality CE-marked endotracheal tubes with subglottic suctioning or antimicrobial coating. These regulations provide an extra stimulus to innovation and enhance product reliability as well as infection resistance which in return fuels market growth for premium tubes.
   
• Many European nations have expanded their healthcare infrastructure post-COVID-19, with targeted funding toward intensive care units (ICUs), emergency services, and surgical departments. As governments upgrade hospitals and increase ventilator capacity, the demand for endotracheal tubes as standard airway equipment has risen significantly. This expansion is especially noticeable in Eastern and Southern Europe, where infrastructure development is catching up with Western standards.
   

Germany endotracheal tube market is projected to grow remarkably in the coming years.
 

• German hospitals focus on hygiene and infection control, especially in critical care and operating departments. In line with these efforts, there is increasing use of endotracheal tubes with subglottic suction and antimicrobial coating designed for the prevention of VAP. Infection control has been enhanced as a result of government initiatives and programs directed toward infection control at the hospital level, stimulating the use of advanced intubation devices.
   
• Germany is the center of high-grade medical equipment manufacturing and a large-scale importer of specialized devices. It also hosts some of the major medical device manufacturers and has streamlined purchasing systems. Such availabilities make it possible for the hospitals and clinics to procure advanced endotracheal tubes with no or minimal interruption in the supply chain, thus driving the market growth in Germany.
   

The Asia Pacific endotracheal tube market is anticipated to grow at the highest CAGR of 8% during the analysis timeframe.
 

• Countries such as India, China, Indonesia, and Vietnam are expanding their healthcare infrastructure with new hospitals, intensive care units, and surgical centers. These projects are leading to the increased consumption of critical medical supplies like endotracheal tubes. With initiatives such as India’s Ayushman Bharat and China’s Healthy China 2030, both countries are able to expand healthcare access which leads to more surgeries and critical care cases requiring intubation.
   
• The development of trauma care, as well as emergency health services, is being advanced in several countries across the Asia Pacific region. These initiatives focus on enhancing ambulance systems, pre-hospital care, and trauma centers in China and South Korea. Greater availability improves necessities, but equipping emergency personnel with functional airway instruments including endotracheal tubes is also required for outside-the-hospital and in-hospital revival actions. Thus, demand is rising from areas beyond the scope of conventional surgery.
   

Japan holds a dominant position in the Asia Pacific endotracheal tube market.
 

• Japan’s population is aging at one of the fastest rates in the world. Over 28% of its citizens are aged 65 and over. This population is more likely to need surgical treatment and intensive care for chronic illnesses, both of which often require endotracheal intubation. Additionally, the geriatric population suffers from cardiovascular disease, stroke, and other age-related disorders which increase the volume of surgical procedures that require secure airway management. As a result, hospitals are stocking specialized breathing tubes for both routine and emergency procedures.
   
• Japan prioritizes safety and precision enriched technology when it comes to medical procedures. For this reason, advanced tubing used for intubating with expanded features is regularly utilized in the country. Strict Japan clinical standards also drive a demand for advanced Subglottic suction, anti-kink design tubes with precise depth markers for enhanced warranty on reduced damage. Enhanced precision in medicine together with Japan's medical advancements drives constant demand for innovative airway devices.
   

Brazil is experiencing significant growth in the Latin America endotracheal tube market.
 

• Brazil's high rate of road traffic accidents and violence-related injuries results in a continuous flow of trauma cases to emergency departments. According to Brazil's Ministry of Health, there were 32,000 traffic-related deaths in 2022, with more than 180,000 hospitalizations due to road accidents. The National Health Surveillance Agency (ANVISA) reported that trauma cases requiring emergency intubation increased by 15% between 2021 and 2023.
   
• These patients frequently require airway stabilization through endotracheal intubation, particularly in pre-hospital and critical care environments.  The Brazilian Society of Emergency Medicine reported that 65% of severe trauma cases in 2023 necessitated urgent airway control, which increased the need for both urban and rural trauma centers to stock reliable endotracheal tubes.
   

Saudi Arabia endotracheal tube market is poised to witness substantial growth in Middle East and Africa market during the forecast period.
 

• Saudi Arabia’s Vision 2030 initiative is heavily focused on expanding and modernizing healthcare infrastructure, including new hospitals, trauma centers, and specialized ICUs. This investment leads to increased procedural volumes requiring airway management, such as surgeries and emergency interventions. The push to upgrade healthcare facilities with advanced medical devices drives the adoption of high-quality endotracheal tubes to meet growing patient care demands.
   
• Saudi Arabia has been improving its emergency medical services (EMS) and trauma response capabilities to better address road accidents and occupational injuries. The enhanced pre-hospital care network has a higher dependency on endotracheal tubes for airway management during patient transport and treatment. The need for intubation devices for field and hospital use is increasing because of improvements in EMS.
   

Endotracheal Tube Market Share

The market is highly competitive in nature with key players such as Medtronic, Teleflex, icumedical, and Fuji Systems, holding around 40% of the market share. These companies compete by offering a diverse product portfolio, integrating cutting-edge technologies such as antimicrobial coatings, laser-resistant materials, and video-guided intubation systems. Additionally, these firms emphasize on innovation in tube design to cater to the growing demand for ICU ventilation, emergency care, and specialized surgical procedures
 

Endotracheal Tube Market Companies

Prominent players operating in the endotracheal tube industry include:

• ANGIPLAST
• Ambu
• Flexicare
• Fuji Systems
• icumedical
• INTERSURGCIAL
• Medline
• Medtronic
• Mercury Medical
• Romed HOLLAND
• STERIMED
• Teleflex
• TUORen
• VIGGOMEDICAL DEVICES
• Wellead
   
• Medtronic global offers a wide range of innovative endotracheal tubes with advanced cuff designs and antimicrobial features. Known for strong clinical support and high regulatory standards worldwide.
   
• Teleflex specializes in airway management with tubes designed for patient safety and difficult airways, including subglottic suctioning options. Widely recognized for reducing trauma and ventilator-associated risks.
   
• Ambu pioneers in single-use airway devices focusing on infection control and ease of use. Their ergonomic designs facilitate rapid intubation and enhance patient comfort.    
   

Endotracheal tube Industry News

• In April 2024, A research team of Rice University based in U.S., developed an innovative pediatric endotracheal tube (ETT) integrated with a camera and anchoring system that made intubation procedures safer for babies aged one month and older by ensuring precise placement, stable anchoring, and visibility access for up to 14 days. This advancement highlights the market’s shift toward safer, more advanced airway management devices, boosting their adoption.
   
• In May 2021, Medtronic plc announced the U.S. commercial launch of the SonarMed airway monitoring system, which utilized acoustic technology to detect endotracheal tube (ETT) obstruction and verify positioning in real-time. This innovation provided clinicians with crucial information to make timely, life-saving decisions for pediatric patients. Such technological advancements are driving growth in the market by improving patient safety and clinical outcomes.
   

The endotracheal tube market research report includes in-depth coverage of the industry with estimates and forecasts in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Product Type

• Regular endotracheal tube
• Reinforced endotracheal tube
• Performed endotracheal tube
• Double lumen endotracheal tube

Market, By Material

• Polyvinyl chloride (PVC)
• Silicon
• Polyurethane
• Other materials 

Market, By Route of Intubation

• Orotracheal
• Nasotracheal 

 Market, By Application

• General surgery
• Emergency treatment
• Therapy
• Neonatal and pediatric care
• Other applications

Market, By End Use

• Hospitals
• Ambulatory surgical centers
• Other end use

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada 
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE